- Home
- CSBR vs PLCE Comparison
CSBR vs PLCE Comparison
Compare CSBR & PLCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CSBR
- PLCE
- Stock Information
- Founded
- CSBR 1985
- PLCE 1969
- Country
- CSBR United States
- PLCE United States
- Employees
- CSBR N/A
- PLCE N/A
- Industry
- CSBR Biotechnology: Biological Products (No Diagnostic Substances)
- PLCE Clothing/Shoe/Accessory Stores
- Sector
- CSBR Health Care
- PLCE Consumer Discretionary
- Exchange
- CSBR Nasdaq
- PLCE Nasdaq
- Market Cap
- CSBR 111.4M
- PLCE 128.9M
- IPO Year
- CSBR 1986
- PLCE 1997
- Fundamental
- Price
- CSBR $8.33
- PLCE $5.00
- Analyst Decision
- CSBR Strong Buy
- PLCE Hold
- Analyst Count
- CSBR 1
- PLCE 1
- Target Price
- CSBR $12.00
- PLCE $6.00
- AVG Volume (30 Days)
- CSBR 39.6K
- PLCE 794.8K
- Earning Date
- CSBR 09-10-2025
- PLCE 06-06-2025
- Dividend Yield
- CSBR N/A
- PLCE N/A
- EPS Growth
- CSBR N/A
- PLCE N/A
- EPS
- CSBR 0.46
- PLCE N/A
- Revenue
- CSBR $58,591,000.00
- PLCE $1,360,516,000.00
- Revenue This Year
- CSBR $15.11
- PLCE N/A
- Revenue Next Year
- CSBR $7.80
- PLCE $1.47
- P/E Ratio
- CSBR $17.71
- PLCE N/A
- Revenue Growth
- CSBR 19.03
- PLCE N/A
- 52 Week Low
- CSBR $3.60
- PLCE $3.66
- 52 Week High
- CSBR $11.99
- PLCE $19.74
- Technical
- Relative Strength Index (RSI)
- CSBR 64.00
- PLCE 56.41
- Support Level
- CSBR $7.16
- PLCE $4.85
- Resistance Level
- CSBR $9.63
- PLCE $4.72
- Average True Range (ATR)
- CSBR 0.64
- PLCE 0.29
- MACD
- CSBR 0.11
- PLCE 0.18
- Stochastic Oscillator
- CSBR 69.06
- PLCE 97.13
About CSBR Champions Oncology Inc.
Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.
About PLCE Children's Place Inc. (The)
Children's Place Inc operate an omni-channel children's specialty portfolio of brands in North America. It designs, contract to manufacture, and sell fashionable, high-quality apparel, accessories and footwear predominantly at value prices under proprietary The Children's Place, Place, Baby Place, Gymboree, Sugar & Jade, and PJ Place brand names. The Company classifies its business into two segments: The Children's Place U.S. and The Children's Place International.